Development and validation of a liquid chromatography-mass spectrometric method for the determination of DPC 423, an antithrombotic agent, in rat and dog plasma

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jan 5;783(1):163-72. doi: 10.1016/s1570-0232(02)00633-5.

Abstract

A sensitive and selective LC-MS-MS method for the determination of DPC 423 (I), an antithrombotic agent, is described. This method used a solid-phase extraction from 0.1 ml plasma with an Isolute C(2) cartridge. HPLC separation was carried out on a YMC ODS-AQ C(18) column (50x2 mm) at a flow-rate of 300 microliter/min with an analysis time of 5 min. Compounds were eluted using a mobile phase of H(2)O/CH(3)CN/HCOOH: 66:34:0.1 (v/v/v), pH 4.0. A structural analogue of I was used as the internal standard to account for variations in recovery and instrument response. Mass spectrometric detection was carried out with a PE Sciex API III(+) triple quadrupole mass spectrometer equipped with a Turbo IonSpray source as the LC-MS interface. Good intra-day and inter-day assay precision (<10% CV) and accuracy (<10% difference) were observed over a concentration range of 0.005-2.5 microM in plasma. The extraction recoveries were approximately 90% and the method was found to be linear for the assay (r(2)>0.999). The method has been successfully applied to discovery and preclinical pharmacokinetic studies, including a dose range-finding study and toxicokinetic exposure studies in rat and dog.

Publication types

  • Validation Study

MeSH terms

  • Adsorption
  • Animals
  • Antithrombins / pharmacokinetics*
  • Chromatography, High Pressure Liquid / methods*
  • Dogs
  • Mass Spectrometry / methods*
  • Pyrazoles / blood*
  • Pyrazoles / pharmacokinetics
  • Rats
  • Reproducibility of Results
  • Sulfones / blood*
  • Sulfones / pharmacokinetics

Substances

  • 1-(3-(aminomethyl)phenyl)-N-(3-fluoro-2'-(methylsulfonyl)(1,1'-biphenyl)-4-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide
  • Antithrombins
  • Pyrazoles
  • Sulfones